Ethos Technologies Inc. LIFE
- Market cap
- $2.3B
- P/E
- 0.0×
Follow LIFE
Target Price Range
Analyst price targets
Free account| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | — |
Analyst estimates 2026–2028 Powerpack |
Low Price | ||
| — | — | — | — | — | — | — | — | — | — | High Price | |||
| — | — | — | — | — | — | — | — | — | 614 |
Employees
|
|||
| — | — | — | — | — | — | — | — | 0 | 1 |
Revenue/Emp
|
|||
| — | — | — | — | — | — | — | — | 255 | 388 |
Revenue
|
|||
| — | — | — | — | — | — | — | — | 100.00% | 100.00% |
Gross Margin
|
|||
| — | — | — | — | — | — | — | — | 54 | 76 |
EBT
|
|||
| — | — | — | — | — | — | — | — | 21.16% | 19.54% |
EBT Margin
|
|||
| — | — | — | — | — | — | — | — | 49 | 71 |
Net Income
|
|||
| — | — | — | — | — | — | — | — | 2 | 5 |
Depreciation
|
|||
| — | — | — | — | — | — | — | — | 15.93 | 23.51 |
Revenue/Sh
|
|||
| — | — | — | — | — | — | — | — | 3.05 | 4.31 |
Earnings/Sh
|
|||
| — | — | — | — | — | — | — | — | (0.68) | 2.20 |
Cash Flow/Sh
|
|||
| — | — | — | — | — | — | — | — | (0.06) | (0.12) |
Capex/Sh
|
|||
| — | — | — | — | — | — | — | — | (0.75) | 2.08 |
Free CF/Sh
|
|||
| — | — | — | — | — | — | — | — | (6.69) | (1.46) |
Book Value/Sh
|
|||
| — | — | — | — | — | — | — | — | 16 | 16 |
Shares
|
|||
| — | — | — | — | — | — | — | — | 0.00 | 0.00 |
PE Ratio
|
|||
| — | — | — | — | — | — | — | — | 0.00 | 0.00 |
PS Ratio
|
|||
| — | — | — | — | — | — | — | — | 0.00 | 0.00 |
PB Ratio
|
|||
| — | — | — | — | — | — | — | — | 0.00 | 0.00 |
EV/Sales
|
|||
| — | — | — | — | — | — | — | — | 4.12 | 4.12 |
EV/FCF
|
|||
| — | — | — | — | — | — | — | — | (11) | 36 |
Op' Cash Flow
|
|||
| — | — | — | — | — | — | — | — | (1) | (2) |
Capex
|
|||
| — | — | — | — | — | — | — | — | (12) | 34 |
FCF
|
|||
| — | — | — | — | — | — | — | — | 201 | 275 |
Working Cap'
|
|||
| — | — | — | — | — | — | — | — | — | — | Total Debt | |||
| — | — | — | — | — | — | — | — | (35) | (91) |
Net Debt
|
|||
| — | — | — | — | — | — | — | — | (107) | (24) |
Sh' Equity
|
|||
| — | — | — | — | — | — | — | — | 0.00% | 15.62% |
ROA
|
|||
| — | — | — | — | — | — | — | — | 0.00% | 0.00% |
ROIC
|
|||
| — | — | — | — | — | — | — | — | 0.00% | (108.41%) |
ROE
|
|||
Ethos Technologies Inc. (LIFE) key facts
- Ethos Technologies Inc.’s revenue for fiscal 2025 (year ended December 2025) was $387.6 million, up 52.0% from fiscal 2024.
- Net income was $71.2 million, or $4.31 per share (basic), a net margin of 18.4%.
- As of September 25, 2026, LIFE traded at $34.30, a market capitalization of $2.3 billion.
- Return on equity was −108.4% and debt-to-equity 0.00.
Ethos Technologies Inc. (LIFE) Latest News
22 Sep
Ethos Technologies Inc. (LIFE) shows growing top line but persistent losses, prompting a reassessment of its $36.19 share price. Over 90 days the stock has surged roughly 100% while year-to-date gains exceed 114%, but near-term trading has been choppy with a 1-day decline of 0.8% and a 7-day slide of 10%. The most-followed fair-value narrative places intrinsic value near $40, indicating ~10% upside, supported by Ethos' underwriting engine that processes vast data and could lift policy throughput and margins as revenue scales. A P/S view at 3.9x compares unfavorably to the broader insurance industry but remains below some growth peers, contributing to valuation ambiguity. The price sits above one internal cash-flow estimate ($29.03) and near a consensus target ($34.88). The bull case depends on rapid top-line expansion translating into sustained profitability; risks include concentrated carrier relationships and ongoing losses. Fair-value upside near $40 and strong momentum imply meaningful upside despite ongoing losses.
3 Sep
Ethos Technologies Inc. (LIFE) reports 113% revenue growth accompanied by margin compression. Revenue surge supports near-term growth outlook but margin pressure signals rising cost challenges that may limit profitability gains.
10 Aug
Ethos Technologies Inc. (LIFE) released its Q2 2026 earnings call transcript covering quarterly financial results, operational updates, and forward guidance. Q2 2026 earnings call delivers financial metrics and outlook that can shift near-term investor sentiment for LIFE.
4 Aug
Ethos Technologies Inc (LIFE) reported Q2 2026 revenue of $190 million, up 113% year-over-year. 113% revenue surge demonstrates accelerated growth that can materially lift valuation and investor outlook.
3 Aug
Ethos Technologies Inc. Class A Common Stock released Q2 earnings call highlights covering financial results and company performance. Q2 earnings highlights provide key financial metrics and outlook that can significantly shift investor views and stock trajectory.
Ethos Technologies Inc. (LIFE) released its second quarter fiscal year 2026 financial results. Quarterly earnings updates deliver financial metrics that can shift near-term market views but rarely transform long-term company trajectory.
10 Jun
Lifecare (OB:LIFE) faces shifting prospects as NOK30 targets encounter execution risks. Execution risks on NOK30 targets introduce moderate challenges to operational and market trajectory.
26 May
Lifecare (OB:LIFE) investment narrative resets after latest valuation cut. Valuation cut shifts investor sentiment and near-term market perception for the company.
6 May
Ethos Technologies Inc. (LIFE) Q1 2026 earnings call transcript released. Q1 earnings call transcript reveals financial results and strategic updates with direct market-moving potential.
Ethos Technologies Inc. (LIFE) released Q1 earnings call highlights for Class A Common Stock. Q1 earnings highlights provide performance details that may shift short-term investor views without altering long-term company path.
Ethos Technologies Inc. (LIFE) reported first quarter fiscal year 2026 financial results. Quarterly earnings release supplies performance data that can shift near-term valuation and sentiment.